Kis Zoltan

Dr. Kis Zoltan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2024 in Viruses
Verified
Journal Article
Open access
PDF file
NDNóra Deézsi-Magyar
Nóra Deézsi-Magyar
Béla DénesBéla Dénes
Béla Dénes
BNBereniké Novák
Bereniké Novák
GZGyula Zsidei
Gyula Zsidei
DDDániel Déri
Dániel Déri
KZKis Zoltan
Kis Zoltan
(1) Background: Crimean–Congo hemorrhagic fever (CCHF) is an emerging tick-borne disease endemic in Africa, Asia, the Middle East, and the Balkan and Mediterranean regions of Europe. Although no human CCHF cases have been reported, based on vector presence, serological evidence among small vertebrates, and the general human population, Hungary lies within high evidence consensus for potential CCHF introduction and future human infection. Thus, the aim of our pilot serosurvey was to assess CCHF seropositivity among cattle and sheep as indicator animals for virus circulation in the country. (2) Methods: In total, 1905 serum samples taken from free-range cattle and sheep in 2017 were tested for the presence of anti-CCHF virus IgG antibodies using commercial ELISA and commercial and in-house immunofluorescent assays. (3) Results: We found a total of eleven reactive samples (0.58%) from five administrative districts of Hungary comprising 8 cattle and 3 sheep. The most affected regions were the south–central and northwestern parts of the country. (4) Conclusions: Based on these results, more extended surveillance is advised, especially in the affected areas, and there should be greater awareness among clinicians and other high-risk populations of the emerging threat of CCHF in Hungary and Central Europe.

27 September 2024 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
NDNóra Deézsi-Magyar
Nóra Deézsi-Magyar
NNNikolett Novák
Nikolett Novák
ALAdrienne Lukács
Adrienne Lukács
KTKatalin Réka Tarcsai
Katalin Réka Tarcsai
ÁHÁgnes Hajdu
Ágnes Hajdu
KSKatalin Szomor
Katalin Szomor
Purpose: In November 2023, the National Reference Laboratory for Enteroviruses (Budapest, Hungary) received stool, pharyngeal swab and cerebrospinal fluid samples from five newborns suspected of having human parechovirus (PEV-A) infection. The neonates were born in the same hospital and presented with fever and sepsis-like symptoms at 8–9 days of age, and three of them showed symptoms consistent with central nervous system involvement. PEV-A positivity was confirmed by quantitative reverse transcription polymerase chain reaction. Methods: To determine the PEV-A genotype responsible for the infections, fecal samples of four neonates were subjected to metagenomic sequencing. For further analyses, amplicon-based whole genome sequencing was performed directly from the clinical samples. Results: On the basis of whole genome analysis, sequences were allocated to PEV-A genotype 3 (PEV-A3) and consensus sequences were identical. Two ambiguities were identified in the viral protein 1 (VP1) region of all sequences at a frequency of 17.7–53.7%, indicating the simultaneous presence of at least two quasispecies in the clinical samples. The phylogenetic analysis and similarity plotting showed that all sequences clustered without any topological inconsistencies between the P1 capsid and P2, P3 non-capsid regions, suggesting that recombination events during evolution were unlikely. Conclusion: Our findings suggest that the apparent cluster of cases were microbiologically related, and the results may also inform future investigations on the evolution and pathogenicity of PEV-A3 infections.

31 October 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
JHJudit Henczkó
Judit Henczkó
ÁTÁkos Tóth
Ákos Tóth
MKMárta Knausz
Márta Knausz
BGBéla Gartner
Béla Gartner
ÁRÁkos Reményi
Ákos Reményi
KZKis Zoltan
Kis Zoltan
Background: Burkholderia pseudomallei, the causative agent of melioidosis, is a neglected tropical pathogen that has been increasingly encountered in Europe through travel-related infections. Clinical manifestations range from localized abscesses to life-threatening sepsis, posing diagnostic challenges in non-endemic regions. Methods: We report two travel-associated melioidosis cases confirmed in Hungary between 2008 and 2024. Whole-genome sequencing (WGS), multilocus sequence typing (MLST), and core-genome MLST (cgMLST) were performed for molecular characterization. In parallel, a systematic review of travel-related melioidosis cases reported in Europe (1980–2025) was conducted according to PRISMA 2020 guidelines. Data were retrieved from PubMed, Scopus, Google Scholar, and the PubMLST database. Results: In silico MLST identified two distinct sequence types (STs): a novel ST1643, and ST1051, previously reported in Asia and Australia. Both isolates clustered within the Asian clade, confirming an imported origin. Virulence profiling revealed major determinants, including the Yersinia-like fimbriae (YLF) cluster, fhaB3, and ITS type C. The ST1643 isolate carried the bimABm variant and multiple resistance genes (blaOXA-57, blaPenI, and amrAB efflux system), while ST1051 harbored blaOXA-59. The literature review identified 82 studies encompassing 195 European cases, most originating from Southeast Asia, with pneumonia, followed by septic form and abscess as the predominant presentation. We found only eight neuromelioidosis cases in Europe. Conclusions: This study represents the first report of neuromelioidosis in Hungary, and the first global description of ST1643. Combined genomic and epidemiological data highlight the need for improved clinical awareness, genomic surveillance, and diagnostic preparedness in non-endemic regions, as global travel and climate change expand the distribution of melioidosis.

7 November 2025 in Archives of Virology
Verified
Journal Article
Open access
PDF file
NDNóra Deézsi-Magyar
Nóra Deézsi-Magyar
BNBereniké Novák
Bereniké Novák
GZGyula Zsidei
Gyula Zsidei
NSNorbert Solymosi
Norbert Solymosi
MMMarianna Mezősi-Csaplár
Marianna Mezősi-Csaplár
KZKis Zoltan
Kis Zoltan
Background Single-stranded RNA viruses such as the Crimean-Congo hemorrhagic fever virus (CCHFV) exhibit a high degree of genetic diversity that can result in the emergence of new viral quasispecies. The aim of this study was to examine the kinetics of CCHFV replication and to identify genetic variations resulting from serial passage in susceptible cell lines that could potentially affect the infectivity and fitness of laboratory virus strains. As efficacy studies of candidate therapeutics and vaccines rely on well-characterized virus stocks, mutations emerging due to virus propagation might result in inaccurate test results. Methods Viral growth kinetics were examined in four cell lines (Vero E6, Vero, SW13, and BHK-21), using different multiplicity-of-infection values. After 10 rounds of serial passaging and cross-passaging, whole-genome sequencing and bioinformatic analysis were performed to map growth-adaptive signature mutations. Results All four cell lines were found to be susceptible to CCHFV infection, and permissivity increased during serial passaging in Vero and BHK-21 cells. Mutations emerged in a cell-line-specific manner, and the particular cell line used for virus propagation had a significant effect on the mutation frequency, especially in the L segment. Conclusions By mapping mutations that occurred during serial passage, we were able to observe viral evolution in a controlled laboratory setting, as well as the accompanying phenotypic changes. Our results provide information about how CCHFV adapts to commonly used cell lines that might be applied for the development of diagnostic tests, antiviral drugs, and vaccines.

9 December 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JHJudit Henczkó
Judit Henczkó
MVMárta Vargha
Márta Vargha
AKAndrás Kállai
András Kállai
KKKatalin Kristóf
Katalin Kristóf
ÁTÁkos Tóth
Ákos Tóth
KZKis Zoltan
Kis Zoltan
Background: Non-O1, non-O139 Vibrio cholerae is an uncommon cause of pneumonia, particularly following freshwater exposure. Non-O1, non-O139 Vibrio cholerae was identified from bronchoalveolar lavage through culture and quantitative polymerase chain reaction (qPCR) in Hungary. During an epidemiological investigation, the source of infection was traced to a designated bathing site at a lake in Central Hungary, where non-O1,non-O139 Vibrio cholerae was isolated from surface water. Methods: We conducted whole-genome sequencing and comparative genomic analysis on a clinical isolate ( N = 1) and three phenotypically distinct environmental isolates ( N = 3). In addition, we reviewed the available literature on pulmonary infections associated with Vibrio cholerae . Results: Core genome multilocus sequence typing (cgMLST) revealed that the clinical and environmental isolates clustered together with zero allelic differences. Multilocus sequence typing (MLST) identified a new sequence type (ST1605), representing a novel combination of known allele variants. In silico analysis of antibiotic resistance genes identified the presence of bla CARB-7. Both the clinical and environmental isolates exhibited identical virulence gene profiles, reinforcing the hypothesis that the infection was acquired from a local water source. Conclusions: This study represents the first investigation of a primary pulmonary Vibrio cholerae infection reported in Europe following a near-drowning event. While Vibrio vulnificus and Vibrio metschnikovii have been implicated in similar pneumonia cases, the precise virulence mechanisms of these species remain poorly understood. Although non-O1, non-O139 Vibrio cholerae infections associated with recreational water exposure are rare in Hungary (1–2 cases per year), this study underscores the importance of ongoing surveillance for the detection of potential outbreaks and to inform public health responses.

23 April 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
JHJudit Henczkó
Judit Henczkó
ZKZsuzsa Kienle
Zsuzsa Kienle
JKJános Kádár
János Kádár
EKEnikő Kádár-Hürkecz
Enikő Kádár-Hürkecz
KTKatalin Tárnoki-Boross
Katalin Tárnoki-Boross
KZKis Zoltan
Kis Zoltan
Background: Brucellosis is a globally distributed zoonotic disease characterized by highly variable clinical manifestations that may mimic systemic autoimmune and inflammatory disorders. In Europe, where the incidence of brucellosis is relatively low, limited clinical awareness may contribute to delayed diagnosis and inappropriate management. In addition to zoonotic transmission, Brucella species are a well-recognized cause of laboratory-acquired infections (LAIs) among microbiology laboratory personnel. Methods: We report a case of laboratory-acquired Brucella abortus infection in a young woman presenting with undulant fever, arthralgia, systemic inflammation, elevated ferritin levels, and antinuclear antibody (ANA) positivity. Microbiological confirmation was achieved through serological testing (ELISA), repeat blood cultures, species-specific quantitative PCR, and whole-genome sequencing (WGS) followed by core genome multilocus sequence typing (cgMLST). Results: Initial laboratory evaluation revealed elevated C-reactive protein, mildly increased ferritin levels (146 ng/mL), abnormal liver enzyme levels, and rising ANA titers (from 1:160 to 1:320), raising suspicion of a systemic autoimmune disorder and prompting consideration of corticosteroid therapy. Although the initial blood culture was negative, subsequent molecular diagnostics and repeat cultures confirmed B. abortus infection. Epidemiological investigation suggested a possible occupational exposure in a diagnostic microbiology laboratory, consistent with a laboratory-acquired infection. Genomic analysis classified the isolate as sequence type 1 (ST1) and demonstrated zero allelic differences compared with the ST1 reference strain. Targeted antimicrobial therapy resulted in complete clinical recovery, supporting an infection-triggered immune response rather than primary autoimmunity. Conclusions: Acute brucellosis should be considered in the differential diagnosis of febrile syndromes accompanied by autoimmune-like laboratory abnormalities, even in low-incidence regions. This case highlights the diagnostic challenges posed by laboratory-acquired brucellosis and underscores the importance of early microbiological investigation and strict biosafety awareness in laboratory settings.